Cardiovascular


Current Activities Go To Past Activities

Current Activities

Live Activities

New Approaches in the Treatment of Coronary Artery Disease

This is a Grand Rounds Program


A series of live, in-hospital grand rounds' activities that will review existing treatment options and their efficacy and safety profiles and explore when each is appropriate to use.



Contemporary Emergency Medicine Perspectives on Venous Thromboembolic Disease
A CME-certified Program

This is a Live Event.


A series of CME-certified programs at select State Chapter Meetings of the American College of Emergency Physicians that aims to update ED personnel on the clinical properties of new oral anticoagulant agents and the appropriateness of traditional vs newer antithrombotic strategies for VTE prophylaxis and its treatment.

Chronic Heart Failure: Expanding the Toolbox of Therapeutic Options
A series of CME-certified Programs

This is a Grand Rounds Program


A Series of CME-certified Symposia at select ACC Chapter Meetings that will provide participants with a better understanding of the difference in pathophysiologic mechanisms between HF with preserved ejection fraction (HFpEF) and HF with reduced ejection fraction (HFrEF).



Practical Use of Anticoagulants to Manage Patients with Atrial Fibrillation:
Preventing Thrombosis, Minimizing Bleeding, and Exploring Reversal Agents

This is a Grand Rounds Program


This CME-certified initiative is intended for general practitioners and other health care providers who are involved in the management of hospitalized patients and out-patients with atrial fibrillation. A series of live CME-certified in-hospital presentations will be held at locations nationwide from 2015-2016.

Antiplatelet Therapy for Secondary CVD Prevention: So Many Choices; What Should We Do?
A series of Live Grand Rounds Programs and a CME-certified Webcourse.

This is a Grand Rounds Program


This CME-certified initiative is intended for all health professionals who are part of the multidisciplinary care team for patients with MI, ACS, or PAD. A series of live CME-certified grand rounds will be presented at selected hospitals throughout the US during 2015, and an online CME-certified webcourse will be available in late 2015.

Cardiology Fellows 2nd Annual Conference

This is a Live Event. View this activity to register.


A series of CME-certified live activities presented by for the Community of Cardiology Fellows that aims to provide exposure and training to increase physicians’ knowledge, competence, and confidence when presented with an ACS emergency.

The Complexities of Stable Ischemic Heart Disease and Its Treatment

This is a Live Event. View this activity to register.


A Series of CME-certified Symposia at select ACC Chapter Meetings that will explore several key issues regarding the diagnosis and management of stable ischemic heart disease (SIHD).

Past Activities Go To Current Activities

Past Activities

Online Activities

Overcoming the Barriers to Managing Acute Ischemic Stroke
Reducing Time of Stroke Onset to Needle Time

Program Type


Only approximately 25% of those who experience an acute ischemic stroke are admitted into a hospital within the 3- to 4.5-hour window recommended by guidelines. In addition, it has been reported that 8%-11.5% of patients presenting to the emergency department (ED) with an acute ischemic stroke are eligible for rt-PA, but only about 2% of those patients receive treatment.

Venous Thromboembolism in Orthopedic Surgical Patients:
Guideline Directed Prophylaxis Therapy

Program Type


This CME-certified webcourse provides clinicians who care for surgical patients undergoing total knee or total hip arthroscopy with the latest clinical evidence surrounding pharmacologic interventions for preventing new onset and recurrent DVT/VTE.

Hyponatremia: Detection and Management in the Hospital Setting

Program Type


An on-demand CME-certified webcourse for hospital-based clinicians who commonly encounter patients with hyponatremia; activity is designed to promote effective and positive changes to clinician knowledge, competence, and confidence, resulting in improved patient care and outcomes.

Addressing Acute Chest Pain Syndrome: Approaches to Prompt Diagnosis and Personalized Treatment of NSTE-ACS Patients

Program Type


An on-demand CME-certified webcourse designed to update community cardiologists and other health care professionals on advances in the management of acute chest pain.

CVD Risk Reduction and Lipid Management: State of the Science in HDL Therapy

Program Type


In this CME-certified webcourse, participants will learn to recognize residual risk associated with even intense statin therapy to lower LDL, as well as the limitations of current therapies to increase HDL, while building an awareness of the prospects of novel therapies to increase HDL and reduce CVD risk in ACS patients.

CVD Risk Reduction and Lipid Management: State of the Science in HDL Therapy

Program Type


This CME-certified enduring activity examines the importance of lipoprotein management for secondary prevention of major adverse cardiac events in post-ACS patients. It is intended for cardiologists and primary care physicians involved in the treatment of patients with dyslipidemia.

COMPLEX CARDIOVASCULAR CASES: NOVEL TREATMENT STRATEGIES FOR HIGH RISK PATIENTS

Program Type


This CME-certified webcourse informs physicians about the latest clinical data and new therapeutic insights regarding treatment options to reduce the risk of major adverse cardiac events in patients with a variety of complex disease states.

Acute Coronary Syndromes: From the Emergency Department to the Coronary Care Unit to the Office

Program Type


This program explores the state-of-the-art treatment of patients with acute coronary syndromes (ACS), and analyzes the latest clinical trial results on new treatment options, while identifying particular patient characteristics that favor one treatment option over another.

The Emergent Science of HDL and its Metabolism: Mechanistic Understanding of CETP Antagonism and Beyond

Program Type


This program is designed to provide clinicians with a sophisticated understanding of the science of lipoprotein metabolism, and a stronger grasp on the complicated mechanisms by which HDL particle number and functionality can be bolstered to enhance the anti-atherogenic properties of HDL and reduce CVD risk.

HYPONATREMIA & CIRRHOSIS: NEW INSIGHTS, NEW THERAPEUTIC CHOICES

Program Type


This CME-certified webcourse informs physicians about new insights regarding the therapeutic and management options for the treatment of hyponatremia in patients with advanced cirrhosis.

CHALLENGES AND NEW STRATEGIES FOR ANTIPLATELET THERAPY IN ATHEROTHROMBOSIS

This CME-certified webcourse informs physicians of the complex nature of platelet activation and the fact that currently available dual antiplatelet therapies may not provide comprehensive inhibition of platelet activation.
Learn More


RECONSIDERING OPTIMAL CARE: CONTROVERSIES IN THE MANAGEMENT OF STABLE ISCHEMIC HEART DISEASE

This CME-certified webcourse describes the key clinical trial data that question the rationale for early interventional treatment of patients with chronic stable ischemic heart disease; discusses the implications of a new treatment option as a first- or second-line therapy for optimal medical treatment; and explains the importance of multifaceted comprehensive management in SIHD patients that includes lifestyle modification, aggressive contemporary polypharmacy approaches, and interventional options when needed.
Learn More


CONTROLLING HYPERTENSION: FROM MECHANISMS TO MANAGEMENT

Participants in this case-based, interactive, CME/CE-certified activity will become more competent in recognizing and managing their patients to blood pressure goals, thereby reducing cardiovascular disease risks and improving patient outcomes.
Learn More


ANTIPLATELET STRATEGIES TO PROTECT ACS PATIENTS AND MINIMIZE RISK

This CME-certified program examines the central role of platelet activation and aggregation in both acute coronary syndrome (ACS) and ischemic complications following percutaneous coronary intervention (PCI) provides a rationale for the use of antiplatelet agents in the prevention and management of these conditions.
Learn More


ACHIEVING CARDIOVASCULAR RISK FACTOR CONTROL: THE ROLE OF RAAS IN CARDIOMETABOLIC DISEASE

This CME-certified newsletter and webcourse are designed to provide support for physicians' continuous improvement of clinical competency and performance to optimize cardiovascular care. The desired result is to improve physicians'/healthcare providers' management of cardiometabolic risk factors with evidence-based therapies to increase the percentage of patients being treated to therapeutic goals.
Learn More


THE COMPLEXITIES OF HEART FAILURE:
Novel Approaches for Management of Resistant Heart Failure


Novel Approaches for Management of Resistant Heart Failure will provide participants with a better understanding of the difference in pathophysiologic mechanisms between HF with preserved ejection fraction (HFpEF) and HF with reduced ejection fraction (HFrEF). Participants will be better able to incorporate evidence-based guidelines and results from large outcomes studies into clinical practice to decrease morbidity and mortality in patients with HF. They will also better understand newer therapeutic targets involved in the pathophysiology of HF, and emerging therapeutic agents that interact with these targets.

Best Practices in SIHD Management:
Advancing a Partnership between Patients, Physicians, and the Heart Care Team


The 2012 guidelines for the diagnosis and management of stable ischemic heart disease (SIHD) present an extensive assessment of the evidence and key issues involved in the diagnosis, risk assessment, treatment, and follow-up of known or suspected SIHD.

Current Approaches and Future Directions in the Management of Patients with Resistant Heart Failure


A Series of CME-certified Symposia at select ACC Chapter Meetings that will provide participants with a better understanding of the difference in pathophysiologic mechanisms between HF with preserved ejection fraction (HFpEF) and HF with reduced ejection fraction (HFrEF).


HIDDEN AREA

TextAreaId:
TextAreaName:
SubFolderPath:
Control Mode: